Abramsky O, Litvin Y (1978) Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson’s disease and schizophrenia. Perspect Biol Med 22(1):104–114

CAS  PubMed  Google Scholar 

Adithya G, Mackie PM, Phan LT, Gámez TM, Habibeh K (2023) The complex role of inflammation and gliotransmitters in Parkinson’s disease. Neurobiol Dis 176:105940

Article  Google Scholar 

Allison S, Gruber-Baldini AL, Rainer von Coelln F, Savitt JM, Reich SG, Armstrong MJ, Shulman LM (2021) Comparison of mini-mental state examination and montreal cognitive assessment ratings across levels of parkinson’s disease severity. J Parkinsons Dis. 11(4):1995–2003

Article  Google Scholar 

Alves G, Lange J, Blennow K, Zetterberg H, Andreasson U, Førland MG, Tysnes O-B, Larsen JP, Pedersen KF (2014) CSF Aβ42 predicts early-onset dementia in Parkinson disease. Neurology 82(20):1784–1790

Article  CAS  PubMed  Google Scholar 

Björn S (2017) Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson’s disease. Neural Regen Res 12(9):1433–1434

Article  Google Scholar 

Chen-Chih C, Lung C, Jia-Hung C, Adebayo BO, Hung-Wen C, Chien-Tai H (2021) Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson’s disease. FASEB J 35(10):e21895

Google Scholar 

Alexa DeMaio, Shikhar M, Kumar S, Shahid H (2022) The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation 19(1):251

Article  Google Scholar 

Ewa P, Ewa K-D, Witold K, Konrad R (2015) Humoral response against small heat shock proteins in Parkinson’s disease. PLoS ONE 10(1):e0115480

Article  Google Scholar 

Fatemeh H, Hassan A, Mehdi T, Abdolrazagh B, Massood NS, Koorosh S (2021) α-synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease. J Neurochem 157(3):727–751

Article  Google Scholar 

Genevieve H, Daniel R, Amanda G, Steven D (2017) Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α. Cancer Immunol Immunother 66(4):523–535

Article  Google Scholar 

Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson’s disease. Mov Disord 29(5):634–650

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu ZX, Song WN, Lu XD, Zhou ML, Shao JH (2018) Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson’s disease. J Biol Regul Homeost Agents 32(3):687–691

CAS  PubMed  Google Scholar 

Hugo G, Francisco C, Rodrigo P (2015) Regulation of the neurodegenerative process associated to Parkinson’s disease by CD4+ T-cells. J Neuroimmune Pharmacol 10(4):561–575

Article  Google Scholar 

Jiajia Fu, Yan H, Ting B, Chengcheng L, Xi L, Xueping C (2022) The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J Neuroinflammation 19(1):98

Article  Google Scholar 

Jiang X, Ganesan P, Rengarajan T, Choi D-K, Arulselvan P (2018) Cellular phenotypes as inflammatory mediators in Parkinson’s disease: interventional targets and role of natural products. Biomed Pharmacother 106:1052–1062

Article  CAS  PubMed  Google Scholar 

Jinar R, Tobias M, Mahshad K, Olle E, Mohsen M, Joakim B, Martin I, Paul O, Healy LM, Anna F, Anna E (2021) Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates. J Neuroinflammation 18(1):124

Article  Google Scholar 

Joseph S, Jahnavi P, Field W, Nathan S, Eric L, Albert C, Karin S, Ken W (2021) NNC 26–9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells. PLoS ONE 16(7):e0254242

Article  Google Scholar 

Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M (2016) Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson’s disease. Sci Rep 6:33738

Article  CAS  PubMed  PubMed Central  Google Scholar 

Magistrelli L, Storelli E, Rasini E, Contaldi E, Comi C, Cosentino M, Marino F (2020) Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson’s disease. Brain Behav Immun. 89:668–674

Article  CAS  PubMed  Google Scholar 

McMillan CT, Wolk DA (2016) Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson’s disease. J Neurol Neurosurg Psychiatry 87(10):1112–1122

Article  PubMed  Google Scholar 

Mery VP, Priti G, Anne-Louise L, Ann R, Andrea B, John KR, Marta K (2017) Reduced cognitive function in patients with Parkinson’s disease and obstructive sleep apnea. Neurology 88(12):1120–1128

Article  PubMed  Google Scholar 

Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Rosen JB, Fink GR, Kessler J, Kalbe E (2015) Cognitive training in Parkinson’s disease reduces cognitive decline in the long term. Eur J Neurol 22(4):640–647

Article  CAS  PubMed  Google Scholar 

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 30:1591–1601

Article  PubMed  Google Scholar 

Shashank S, Rahul K, Nitish R, Vijay K, Kusum S, Datt UA, Manjari T, Sadanand D, Dey AB, Sharmistha D (2016) Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer’s disease and mild cognitive impairment patients. PLoS ONE 11(7):e0159099

Article  Google Scholar 

Soileau MJ, Pagan FL, Alfonso F, Ramon R-C, Yan CH, Gupta NR, Teigland CL, Zulkarnain P, Schinkel JK, Kandukuri PL, Ladhani OA, Siddiqui MS (2023) Comparative effectiveness of carbidopa/levodopa enteral suspension and deep brain stimulation on pill burden reduction in medicare fee-for-service patients with advanced Parkinson’s disease. Neurol Ther. https://doi.org/10.1007/s40120-022-00433-w

Article  PubMed  PubMed Central  Google Scholar 

Sule T-U, Yesim N, Karabulut DS, Merve Z, Sevim I (2017) Cellular model of Alzheimer’s disease: Aβ1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIβ and Nurr1 expression. Curr Alzheimer Res 14(6):636–644

Article  Google Scholar 

Tomas S, Aladar M, Jana F, Ondrej K, Santosh J, Martin C, Veronika B, Michal N, Norbert Z (2016) Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment. J Comp Neurol 524(4):874–895

Article  Google Scholar 

Walter M, Daniela B (2018) Parkinson disease in 2017: changing views after 200 years of Parkinson disease. Nat Rev Neurol 14(2):70–72

Article  Google Scholar 

Weinshel S, IrwinDavid J, Zhang P, Weintraub D, Shaw LM, Siderowf A, Xie SX (2022) Appropriateness of applying cerebrospinal fluid biomarker cutoffs from Alzheimer’s disease to Parkinson’s disease. J Parkinsons Dis 12(4):1155–1167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wenbin W, Lan C, Lumei L, Chunyan Z, Bill K, Xiantao T, Yaming Li, Shijin X (2015) Aβ(1–42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem 134(2):382–393

Article  Google Scholar 

Williams Gregory P, Schonhoff Aubrey M, Jurkuvenaite A, Gallups Nicole J, Standaert David G, Harms Ashley S (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson’s disease. Brain 144(7):2047–2059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woo NS, Hee HY, Woong MC, Joo CE, Gyu KE, Hwan JK, Hwa SJ, Jin KS (2014) Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson’s disease with mild cognitive impairment. J Neurol Sci 347:210–213

Article  Google Scholar 

Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Cristina N, Sophie W-R, Evans JR, Rowe JB, Brit M, Niels K, Gavin H, Chinnery PF, O’Brien JT, Robbins TW, Keith W, Brooks DJ, Barker RA, Burn DJ, ICICLE-PD Study Group (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82(4):308–316

Article  PubMed  PubMed Central  Google Scholar 

Zhang MY (1989) Application of Chinese version of simple intelligent state check (MMSE). Shanghai J Psychiatr. 007(3):108–111

Google Scholar